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introduction: Transoral laser microsurgery (TLM) represents one of the most effective 
treatment strategies for Tis–T2 glottic squamous cell carcinomas (SCC). The prognostic 
influence of close/positive margins is still debated, and the role of narrow band imaging 
(NBI) in their intraoperative definition is still to be validated on large cohort of patients. 
This study analyzed the influence of margin status on recurrence-free survival (RFS) and 
disease-specific survival (DSS).
Methods: We retrospectively studied 507 cases of pTis–T1b (Group A) and 127 cases of 
pT2 (Group B) glottic SCC. We identified the following margin status: negative (n = 232), 
close superficial (n = 79), close deep (CD) (n = 35), positive single superficial (n = 146), 
positive multiple superficial (n = 94), and positive deep (n = 48) and analyzed their impact 
on RFS and DSS. Close margins were defined by tumor-margin distance <1 mm. Pre-
TLM margins were defined by white light in 323 patients, whereas NBI was employed in 
311 patients.
results: In Group A, DSS and RFS were reduced in positive multiple superficial and 
positive deep margins (DSS = 96.1 and 97%, both p < 0.05; RFS = 72%, p < 0.001 
and 75.8%, p <  0.01). In Group B, DSS was reduced in positive multiple superficial 
margins (82.4%, p <  0.05). RFS was reduced in positive single superficial, positive 
multiple superficial, and positive deep margins (62.5, 41.2, and 53.3%, p < 0.01). In the 
entire population, RFS was reduced in CD margins (77.1%, p < 0.05). Use of NBI led to 
improvement in RFS and DSS.
conclusion: The study indicates that close and positive single superficial margins 
do not affect DSS. By contrast, all types of margin positivity predict the occurrence of 
relapses, albeit with different likelihood, depending on stage/margin type. CD margins 
should be considered as a single risk factor. Use of NBI granted better intraoperative 
margins definition.
Keywords: laryngeal cancer, early glottic cancer, transoral laser microsurgery, cO2 laser, surgical margins, 
endoscopy, recurrence-free survival, disease-specific survival
Table 1 | Demographic characteristics, patients’ stratification by pTNM, margin 
status, and types of cordectomy performed.
Variables entire cohort group a group b
Number of patients 634 507 127
Age 64.1 ± 10.4 64.1 ± 10.2 64.3 ± 11.2
Male/female 560/74 467/40 93/34
T category
pTis 102 102 –
pT1a 316 316 –
pT1b 89 89 –
pT2 127 – 127
Margin status, no. (%)
NEG 231 (36.4) 199 (39.2) 32 (25.2)
CS 79 (12.4) 58 (11.4) 21 (16.5)
CD 35 (5.5) 25 (4.9) 10 (7.9)
SS 146 (23) 114 (22.5) 32 (25.2)
MS 94 (14.8) 77 (15.2) 14 (13.4)
DEEP 48 (7.5) 33 (6.5) 15 (11.8)
Type of cordectomy
I 48 48 –
II 275 262 –
III 122 111 –
IV 40 27 23
V 141 56 99
VI 8 3 5
NEG, negative margin; CS, close superficial; CD, close deep; SS, positive single 
superficial; MS, positive multiple superficial; DEEP, positive deep margins.
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inTrODUcTiOn
Early glottic squamous cell carcinoma (SCC) has an excellent 
local control rate (LCR) independently of the treatment choice. 
In particular, for T1 category, LCR is reported to range from 
86 to 95% for transoral laser microsurgery (TLM) and from 85 
to 94% for radiotherapy (RT) (1–4). In T2 lesions, RT shows 
a slightly worse LCR, ranging from 67 to 76%, with respect to 
TLM (76–89%) (1–8). However, a large meta-analysis of 11 
studies, involving 1,135 patients, failed to identify any difference 
in LCR of patients with early glottic SCC receiving TLM or RT, 
even though overall costs were lower with TLM (7). Despite the 
above reported similar LCR, present evidence suggests that RT 
may perform worse than TLM in terms of disease-free survival 
(9); moreover, the radiation therapy approach seems to entail a 
higher risk for subsequent total laryngectomy in comparison with 
TLM (10).
On the other hand, the choice of TLM implies the assessment 
of a series of patient-dependent and technique-related factors, to 
obtain the most favorable therapeutic outcome (11–14). One of 
the most influencing factors in TLM is definitively represented 
by surgical margins status after surgery. This issue is complicated 
by the lack of a homogeneous definition of negative, close, and 
positive margins. In fact, most authors define a margin as “nega-
tive” when the tumor-margin distance is >1 mm, “close” when 
the distance is <1 mm, and “positive” in presence of tumor at the 
surgical edge. However, management of patients with close and 
positive margins is still controversial (15–18). Specific indications 
for surgical re-treatment (by TLM or open-neck approaches) or 
complementary RT and the impact of such adjuvant treatments 
on recurrence-free survival (RFS) and disease-specific survival 
(DSS) are not yet clearly defined.
In light of this, we retrospectively analyzed a large homogene-
ous cohort of patients affected by early glottic SCC treated by 
TLM, focusing our attention on the impact of close and positive 
surgical margins on RFS and DSS, and on the possibility to reduce 
their rates by using new biologic endoscopy tools such as narrow 
band imaging (NBI).
MaTerials anD MeThODs
We retrospectively analyzed data from a series of 634 untreated 
patients (560 males, 74 females; mean age, 64.1 ± 10.4 years; age 
range, 30–88) affected by Tis–T2 glottic SCC who underwent 
TLM from January 2000 to March 2014 at the Departments of 
Otorhinolaryngology—Head and Neck Surgery, University of 
Genoa and Brescia, Italy (Table 1). All patients signed a written 
informed consent, which was reviewed and approved by the local 
Ethics Committees and including the use of anonymized patient 
data for research purposes.
The tumors were intraoperatively assessed by both 0° and 70° 
rigid telescopes (Olympus Medical System Corporation, Tokyo, 
Japan and Karl Storz, Tuttlingen, Germany), increasing the 
accuracy of neoplastic superficial spreading evaluation (19). In all 
patients since January 2008, preoperative videolaryngoscopy was 
combined with high definition television (HDTV)-NBI (Olympus 
Medical System Corporation, Tokyo, Japan) (20). In selected 
cases, CT or MR was carried out to evaluate anterior commissure, 
visceral spaces, and laryngeal framework involvement.
Adequate laryngeal exposure in microlaryngoscopy was 
obtained by different laryngoscopes comprising Sataloff 
(Microfrance®iXomed, Saint Aubin Le Monial, France), Dedo, 
and Dedo-Ossoff (Pilling, Philadelphia, PA, USA). The lasers 
used were the Sharplan 1055 S (Sharplan, Tel Aviv, Israel) from 
2000 to 2004, and the UltraPulse/Surgitouch CO2 laser (Lumenis, 
Yokneam, Israel) from 2004 to 2014.
Patients were treated by six different types of cordectomies 
according to the European Laryngological Society classification 
(Table  1), using “en bloc” or “multi bloc” approaches, in rela-
tion to the tumor site, size, category, depth of infiltration, and 
laryngeal exposure (21–23). Frozen sections were not routinely 
performed. Extra-surgical margins, when deemed necessary, 
were taken from the surgical bed after resection of larger lesions 
and sent separately for definitive histopathologic examination.
On the basis of histopathological reports, the entire cohort 
was divided in two groups: Group A included 507 (102 pTis, 316 
pT1a, and 89 pT1b) subjects and Group B 127 (all pT2) patients 
(Table 1), staged according to the seventh TNM classification by 
the American Joint Committee on Cancer (17).
We defined surgical margins as follows: negative (distance 
tumor-margin >1 mm), close (distance tumor-margin between 0 
and 1 mm), and positive (presence of at least carcinoma in situ at the 
surgical margin). In case of extra-surgical margins taken at the end of 
procedure, these were considered as the definitive surgical margins.
Median follow-up for the entire cohort of patients was 
60 months (range, 12–176): those staged as pTis–pT1b with nega-
tive margins were followed by videolaryngoscopy every 2 months 
in the first year, every 3 months in the second, every 4 months in 
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the third, every 6 months in the fourth, and once a year afterward. 
In patients staged as pT2, MR or CT was added every 6 months for 
the first 2 years of follow-up even if the endoscopy was negative.
In case of close margins and/or single positive superficial 
margin, a monthly follow-up and, where indicated, periodic 
imaging were performed. In case of positive multiple superficial 
or deep margins, intraoperative recording was reviewed and, after 
multidisciplinary discussion, an adjuvant treatment (transoral 
re-resection, open partial laryngectomy, or adjuvant RT) was 
proposed to the patient. Whenever this option was refused by 
the patient or deemed too risky for his/her general conditions, a 
strict watch-and-see policy was followed.
statistical analysis
The SPSS program (SPSS, v. 21.0, IBM, Armonk, NY, USA) was 
used for statistical analysis. Five-year survival curves were plotted 
using the Kaplan–Meier method; pairwise over strata log-rank 
test was used to detect survival differences between groups. 
Analysis was first performed for the entire patient population and 
then separately for Groups A and B.
The entry point was the date of laser cordectomy. Differences 
between survival curves were assessed using log-rank test for mar-
gin status variables. Six different margin statuses were considered 
for the Kaplan–Meier survival curve: negative (NEG), close super-
ficial (CS), close deep (CD), positive single superficial (SS), positive 
multiple superficial (MS), and positive deep margins (DEEP).
The first studied outcome was DSS, with the end point being 
patient’s death or last follow-up (censored observations, shown 
as “+” symbol along the survival line). Patients who died of 
unrelated causes were excluded from the analysis. The second 
outcome was RFS, with the end point set at the date of recur-
rence or at the last available visit (censored observations). Organ 
preservation (OP) was the third measured outcome, with the end 
point set at the date of total laryngectomy or at last follow-up 
(censored observations).
Influence of the routine use of HDTV-NBI in defining super-
ficial resection margins and its impact on RFS, DSS, and OP were 
also investigated by comparing recurrence rates, disease-specific 
lethal events, and need for total laryngectomy between patients 
treated before NBI implementation (pre-NBI group, 2000–2007) 
vs. those operated on thereafter (NBI group, 2008–2014). This 
analysis was carried out for the entire group of patients, and for 
Group A, Group B, and pT1a lesions separately. Differences in 
number of events between the pre-NBI and NBI groups were 
assessed using chi-squared or Fisher’s exact tests, as appropriate.
Moreover, relative risk of relapse related to margin positivity, 
age, tumor stage, use of HDTV-NBI for margin definition, and 
additional treatment after the intervention was tested by using 
a Cox multivariate model with backward logistic regression. For 
T2 patients, influence of tumor pattern of spread (i.e., transcom-
missural, supraglottic, and subglottic extension, as well as muscle 
infiltration) was further tested with the same model.
resUlTs
Among all patients, 288 (45.4%) had positive margins. In particu-
lar, 146 (23%) had positive single superficial margins, 94 (14.8%) 
positive multiple superficial margins, and 48 (7.5%) positive 
deep margins. One hundred fourteen patients (18%) had close 
margins, among which 79 (12.5%) CS and 35 (5.5%) CD margins 
(Table 1).
impact of Margin status on Dss
In the entire cohort, patients with multiple positive superficial 
margins (MS) had reduced DSS compared with those with negative 
ones (93.6 vs. 100%, p = 0.005, Figure 1). In details, in Group A, 
both positive multiple superficial (MS) and positive deep margins 
(DEEP) status were related to a slight, yet significant, reduction 
in DSS (96.1 and 97%, respectively vs. 100%, p < 0.05, Figure 2), 
whereas in Group B all events were observed in patients affected 
by positive multiple superficial margins (MS) compared with 
those with negative ones (82.4 vs. 100%, p = 0.019, Figure 2).
impact of Margin status on rFs
Overall, RFS was affected by margin status, as 88.2% of patients 
with negative and close margins were recurrence free at their last 
follow-up, compared with 73.3% of patients with positive margins 
(p < 0.001). All subtypes of margins positivity predicted recur-
rence: RFS for SS, MS, and DEEP margins was 78.8% (p < 0.01), 
67% (p < 0.001), and 68.8% (p < 0.001), respectively (Figure 3). 
At multivariate Cox regression, relative risk of recurrence for this 
three margin infiltration patterns was 2.1, 3.7, and 3.4, respec-
tively (p < 0.01, Table 2).
In Group A, patients with positive margins had a 78.6% RFS, 
which was reduced in comparison with patients with both nega-
tive and close margins together (89.4%, p < 0.05). Overall, the dif-
ference between negative and all positive margins was significant 
(p =  0.002); in particular, RFS for SS, MS, and DEEP margins 
was 83.3% (p = NS), 72.7% (p < 0.001), and 75.8% (p < 0.01), 
respectively. Anterior commissure involvement did not associate 
with lower RFS (93.5% in tumors reaching the anterior commis-
sure vs. 93.6% in those not involving this subsite, p = NS).
In Group B, if patients with negative and close margins were 
considered as a single group, RFS was 82%. All subtypes of 
margin positivity were indicative of worse RFS, which decreased 
to 54.7% in patients whose resection margins were positive 
(p <  0.01). Specifically, the percentage of patients with no evi-
dence of recurrence throughout follow-up was 62.5% (p < 0.05), 
41.2% (p < 0.001), and 53.3% (p = 0.012) for SS, MS, and DEEP 
margin positivity, respectively. Different tumor extension (trans-
commissural, supraglottic, subglottic, or massive vocal muscle 
infiltration) did not show any differences in RFS (68.2, 67.8, 70.7, 
and 74.4% respectively, p = NS) (Figure 4).
impact of close Margins
Close margins did not affect DSS. In the entire population, 
patients with CS margins did not show a significant decrease in 
RFS (81%, p = NS); conversely, the presence of CD margins was 
related to a significantly increased number of relapses with an 
RFS of 77.1% and a relative risk of 2.6 (Table 2, p < 0.05).
Organ Preservation
Deep margin infiltration predicted a worse OP in Group A. 
In fact, no patients with negative margins had to be treated by 
FigUre 1 | Kaplan–Meier curves for the entire patients cohort showing disease-specific survival in relation to margin status. MS, positive multiple superficial 
margins; SS, positive single superficial margin; “+” symbol, censored observations.
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total laryngectomy, while 6.1% of those with positivity of the deep 
margin lost the larynx (p < 0.01). No significant difference was 
observed in Group B. Detailed figures regarding RFS, DSS, and 
OP are shown in Table 3.
impact of additional Treatment
Twelve of 94 patients (12.8%) with positive MS margins under-
went additional treatment (11 TLM and 1 adjuvant RT) due to 
the presence of adjunctive histopathologic risk factors such as 
high-grade lesions, evidence of perineural spread and/or vascular 
embolization. The presence of such selection bias could explain 
why these patients had worse RFS (50%) than those who did not 
undergo re-treatment (69.5%, p = 0.03).
Fifteen of 48 patients (31.2%) with positive deep margins 
underwent additional treatment (9 TLM and 6 adjuvant RT). 
Among these, additional treatment showed slight, though 
non-significant improvement of RFS (73.3%) compared with 
those who received no further treatment (66.7%, p =  NS). 
Detailed figures regarding additional treatments are available 
in Table 4.
impact of hDTV-nbi on Margins 
evaluation, rFs, Dss, and OP
In all patients, intraoperative use of HDTV-NBI allowed improved 
evaluation of surgical margins, with a greater proportion of 
negative margins (50 vs. 30%, p < 0.001), reduced number of CS 
(10 vs. 16%, p < 0.001), and multiple superficial margins (15 vs. 
17%, p = 0.03). Improvement of the rate of negative margins was 
also observable in Group A (45 vs. 34%, p < 0.001) and in pT1a 
patients (44 vs. 31%, p < 0.001). Moreover, use of HDTV-NBI 
reduced the postoperative findings of CS (8 vs. 15%, p < 0.001) 
and multiple superficial positive margins (13 vs. 18%, p = 0.01) 
in both Group A and pT1a patients (9 vs. 18%, p < 0.001; 10 vs. 
17%, p < 0.001, respectively).
FigUre 2 | Kaplan–Meier curves showing disease-specific survival in relation to margin status for each group of patients. MS, positive multiple superficial margins; 
SS, positive single superficial margin; “+” symbol, censored observations.
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In Group B, use of NBI significantly improved the relative 
number of negative margins (46 vs. 15%, p < 0.001), while CS 
(24 vs. 29%, p < 0.001) and single superficial positive margins (13 
vs. 21%, p < 0.001) were significantly reduced. As expected, NBI 
did not affect the rate of positive or CD margins.
In all patients, use of NBI significantly improved RFS (83.9 vs. 
78.9% p < 0.05). Such improvement was particularly appreciable 
in negative (94.1 vs. 89.6%, p <  0.01) and multiple superficial 
margins (75 vs. 61.1%, p < 0.001). Relative risk, as calculated by 
multivariate Cox regression, was reduced in patients treated with 
the help of HDTV-NBI (0.61, p < 0.05) (Table 2).
Similarly, NBI was beneficial in negative and MS margins 
when Group A (p <  0.001) or pT1a lesions (p =  0.01) were 
considered. No difference in RFS was detected in Group B. Use 
of HDTV-NBI also improved DSS in patients with MS margins 
(Table 5).
impact of additional Factors on survival
At multivariate Cox regression analysis, the main factor having 
an impact on RFS was the surgical margin status (p <  0.001) 
(Table 2). All margin positivity affected RFS; however, in accord-
ance to what demonstrated by the Kaplan–Meier model, multiple 
superficial and deep margin infiltrations were associated with the 
highest risk increase (Table 2). Other factors showing a significant 
incidence on RFS were T category (p < 0.01), with T1b and T2 
lesions showing increased risk (p < 0.05), and use of HDTV-NBI, 
exerting a protective effect against future recurrences (p < 0.05). 
Age, adjuvant treatment and, for T2 tumors, presence of specific 
patterns of spread such as transcommissural, supraglottic, sub-
glottic, or massive muscle infiltration, did not affect the risk of 
developing relapse.
DiscUssiOn
Transoral laser microsurgery is a surgical approach that has 
emerged as a viable alternative to open-neck approaches and RT 
as it allows sound oncological results, while preserving organ 
function and ensuing high salvage rates in case of persistent/
recurrent or secondary laryngeal tumors (1–8). Moreover, its 
favorable cost-effectiveness ratio profile could be helpful in 
Table 2 | Cox regression analysis of factors affecting recurrence-free survival.
B sig. exp (B) ci 95.0% for 
exp (B)
lower Upper
all patients
Margins <0.001 3.703 2.055 6.672
Age NS 1.002 0.984 1.021
Additional treatment NS 1.113 0.586 2.113
TNM stage 0.371 0.002 1.853 0.975 3.522
Narrow band imaging −0.491 0.016 0.612 0.411 0.911
T2 patients
Transcommissural 
infiltration
0.06 NS 1.062 0.452 2.496
Muscle infiltration 0.667 NS 1.949 0.939 4.043
Hypoglottic infiltration −0.228 NS 0.796 0.363 1.746
Supraglottic infiltration −0.071 NS 0.932 0.419 2.071
B, beta coefficient; Wald, Wald statistic; df, degrees of freedom; Exp (B), hazard ratio or 
relative risk; CI 95.0% for exp (B), confidence interval 95.0%; NS, non-significant.
FigUre 3 | Kaplan–Meier curves for the entire patients cohort showing recurrence-free survival in relation to margin status. MS, positive multiple superficial margins; 
SS, positive single superficial margin; “+” symbol, censored observations.
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containing ever-growing healthcare costs (7). This type of surgery 
is mostly applied in early-stage disease and is characterized by 
a very narrow-margin approach, which makes the process of 
performing a safe and clean resection challenging. Moreover, the 
use of laser invariably leads to tissue dehydration and consequent 
margin shrinkage, which further reduces the ability to obtain 
widely negative surgical margins at histopathological examina-
tion (23). These two aspects force the surgeon to put significant 
effort in balancing between the best oncological and functional 
outcomes in each patient.
Actually, one of the most important prognostic factors in 
TLM remains the status of surgical margins (11, 14, 16). In 
the present series, we confirmed the feasibility and oncological 
soundness of this technique, as demonstrated by the high RFS 
and DSS rates, which favorably compare to those reported in 
the literature (1, 5, 6). Moreover, it should always be kept in 
mind that, in TLM for early glottic SCC, RFS does not neces-
sarily have a significant impact on DSS, LCR, or OP, due to the 
high percentage of recurrences that are salvageable by further 
7Fiz et al. Margin Status Impact in TLM 
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FigUre 4 | Kaplan–Meier curves showing recurrence-free survival in relation to margin status for each group of patients. MS, positive multiple superficial margins; 
SS, positive single superficial margin; “+” symbol, censored observations.
Table 3 | Five-year disease-specific survival (DSS), recurrence-free survival 
(RFS), and organ preservation (OP) for the entire cohort, and for Groups A and B.
Dss (%) rFs (%) OP (%)
all patients
NEG 100 92.2 98.7
CS 98.7 81 98.7
CD 100 77.1* 91.4*
SS 100 78** 97.3
MS 93.6** 67*** 95.7
DEEP 97.9 68*** 95.8
group a
NEG 100 93 100
CS 98.3 79.3* 100
CD 100 84 96**
SS 100 83.3 99.1
MS 96.1* 72*** 98.7
DEEP 97* 75.8** 93.9**
group b
NEG 100 87.5 90.6
CS 100 85.7 95.2
CD 100 60 80
SS 100 62.5* 90.6
MS 82.4* 41.2*** 82.4
DEEP 100 53.3* 100
p-Values for comparisons between negative margins and all kinds of positive/close 
margins are indicated as (*) when <0.05, (**) when <0.01, and (***) when < 0.001.
NEG, negative margin; CS, close superficial; CD, close deep; SS, positive single 
superficial; MS, positive multiple superficial; DEEP, positive deep margins.
Table 4 | Impact of additional treatments in all patients on RFS.
Positive multiple 
superficial 
margins
Positive deep 
margins
Patients 94 RFS 48 RFS
Without additional treatment 82 69.5% 33 66.7%
With additional treatment 12 50% 15 73.3%
p 0.03 NS
RFS, recurrence-free survival; NS, non-significant.
conservative treatment options (1). In fact, our data show that 
even when surgery is executed in the best-case scenario and the 
surgical margins are completely clean, recurrence is still possible 
and may affect up to one-tenth of all patients during follow-up. 
This figure shows a slight variation according to tumor category, 
which is, however, of minor significance. Use of HDTV-NBI 
further improved this outcome, as only one in 20 patients with 
negative margins suffered from disease recurrence after intro-
duction of this bio-endoscopic tool in our routine practice. No 
patient with negative margins died of disease, thus confirming 
their good prognostic role.
The same line of thinking can be applied to close surgical 
margins, as no such patient died of disease. However, the surgeon 
may expect a higher recurrence rate with respect to fully negative 
8Fiz et al. Margin Status Impact in TLM 
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Table 5 | Impact of narrow band imaging (NBI) on 5-year recurrence-free 
survival (RFS) and disease-specific survival (DSS) for the entire cohort of patients, 
for Groups A and B, and for pT1a patients.
Patients (%) rFs (%) Dss (%)
Pre-nbi nbi Pre-nbi nbi Pre-nbi nbi
All patients 323 311 78.9 83.9* 98.8 98.7
NEG 96 (30) 136 (50)*** 89.6 94.1** 100 100
CS 53 (16) 26 (10)*** 90.6 73.1 100 96.2
SS 78 (24) 68 (25) 80.8 76.5 100 100
MS 54 (17) 40 (15)* 61.1 75*** 92.6 95*
Group A (Tis–T1) 251 256 83.3 87.1 99.2 98.8
NEG 85 (34) 115 (45)*** 89.4 95.6*** 100 100
CS 38 (15) 20 (8)*** 89.5 75 100 95
SS 57 (23) 57 (22) 94.3 79 100 100
MS 45 (18) 32 (13)** 66.7 81.2*** 95.6 96.9
T1a 160 157 86.3 86.5 99.4 99.4
NEG 50 (31) 69 (44)*** 90 97.1*** 100 100
CS 29 (18) 14 (9)*** 93.1 64.3 100 97.7
SS 36 (23) 36 (23) 86.1 77.8 100 100
MS 27 (17) 15 (10)*** 74.1 80** 100 97.6
Group B (T2) 72 55 68.1 69.1 97.2 98.2
NEG 11 (15) 21 (38)*** 90.9 85.7 100 100
CS 15 (21) 6 (11)*** 93.3 66.7 100 100
SS 21 (29) 11 (20)*** 61.9 63.6 100 100
MS 9 (13) 8 (15) 33.3 50 77.8 87.5
p-Values for comparisons between the pre-NBI group of patients and the NBI group in 
evaluation of margins are indicated as (*) when <0.05, (**) when <0.01, and (***) when 
<0.001.
NEG, negative margin; CS, close superficial; CD, close deep; SS, positive single 
superficial; MS, positive multiple superficial; DEEP, positive deep margins.
borders, especially in the presence of CD margins, which signifi-
cantly affected the recurrence rate in our series.
Single superficial margin infiltration had an overall impact on 
RFS, which was not significantly divergent from CS margins; it has 
to be noted, however, that, in the setting of T2, risk of recurrence 
tends to be significant, as 4 in 10 patients were found with recur-
rence during the course of their follow-up. Again, surveillance 
in these patients allowed thwarting any disease-related death 
and DSS was not statistically different from negative and close 
margins. Moreover, use of HDTV-NBI was especially beneficial 
in T2 patients, reducing the number of single superficial margin 
positivity.
It may be surmised that, even though CS and single superficial 
margins appear to be hallmarks of imperfect disease control, 
strict follow-up may be sufficient in avoiding the most severe 
outcomes. Further prospective studies could be aimed to test 
the validity of such approach against the routine application of 
adjuvant RT and/or repeated TLM. Our data, however, confirm 
that CD margins do have an impact on RFS and should not be 
overlooked.
Actually, even though fatal outcome is a rare occurrence in 
early glottic SCC (1), the vast majority of events clustered in 
patients with multiple superficial positive margins. This sub-
population, along with patients with deep margin infiltration, 
was also burdened by the highest recurrence rate. Moreover, in 
case of deep margin infiltration, we observed an increased need 
for total laryngectomy. Our results do not indicate a significant 
improvement in RFS with the application of adjuvant treatment. 
However, this analysis was limited by the reduced sample size and 
by patient selection bias; therefore, to draw any definite conclu-
sions, large controlled prospective trials are needed.
This study has several limitations. First, it is retrospective in 
nature, analyzing pathologic data gathered at two different insti-
tutions over a relatively long time period. Moreover, follow-up 
was variable, as some patients, treated in the early 2000s, stopped 
attending visits after a long remission period, while others were 
recruited at relatively recent dates.
Overall, this study offers a possible key of interpretation of 
margin results in the framework of clinical decision during long-
term follow-up. In particular, it suggests caution in presence of 
positivity of deep or multiple superficial margins, as these find-
ings are hallmarks of possible disease persistence, especially in 
higher T categories. Patients with close margins, however, as well 
as those with single superficial margins, could undergo rigorous 
follow-up, as their recurrence rate is slightly higher.
cOnclUsiOn
Our data confirm that TLM for early-stage glottic SCC offers 
sound results in terms of DSS and RFS, as well as a high rate of OP. 
Survival-related parameters can be effectively stratified by margin 
status, even though larger studies are needed to definitively assess 
the opportunity, type, and outcomes of additional treatments in 
case of positive margins.
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